Cargando…
More evidence that direct acting antiviral therapy is safe and effective in cirrhosis and chronic kidney disease including peritoneal dialysis
Autores principales: | Kwo, Paul, Dronamraju, Deepti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641542/ https://www.ncbi.nlm.nih.gov/pubmed/32967407 http://dx.doi.org/10.3350/cmh.2020.0228 |
Ejemplares similares
-
Primary Biliary Cirrhosis: Environmental Risk Factors
por: Dronamraju, Deepti, et al.
Publicado: (2010) -
Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals
por: Nguyen, Kelvin, et al.
Publicado: (2017) -
Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis
por: Toshikuni, Nobuyuki
Publicado: (2017) -
Peritoneal Dialysis in Diabetics: There Is Room for More
por: Cotovio, P., et al.
Publicado: (2011) -
Drug-drug interactions with direct-acting antivirals — less is more
por: Wong, Grace Lai-Hung
Publicado: (2021)